Transient Myopericarditis Following Vaccination for COVID-19

Clinical trials of the messenger ribonucleic acid (mRNA)-1273 vaccine developed by Moderna proved excellent safety and efficacy for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) prevention. However, the Centers for Disease Control and Prevention (CDC) has been investigating cases of m...

Descripción completa

Detalles Bibliográficos
Autores principales: Gill, Jashan, Mallari, Arvin Junn P., Zahra, Farah
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elmer Press 2022
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8913003/
https://www.ncbi.nlm.nih.gov/pubmed/35317093
http://dx.doi.org/10.14740/jmc3876

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8913003/
https://www.ncbi.nlm.nih.gov/pubmed/35317093
http://dx.doi.org/10.14740/jmc3876

Ejemplares similares